Search by Drug Name or NDC
NDC 00024-4512-24 Fexinidazole 600 mg/1 Details
Fexinidazole 600 mg/1
Fexinidazole is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sanofi-Aventis U.S. LLC. The primary component is FEXINIDAZOLE.
Product Information
| NDC | 00024-4512 |
|---|---|
| Product ID | 0024-4512_f17ba6ea-25d5-23c3-e053-2a95a90ab2a6 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Fexinidazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fexinidazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 600 |
| Active Ingredient Units | mg/1 |
| Substance Name | FEXINIDAZOLE |
| Labeler Name | Sanofi-Aventis U.S. LLC |
| Pharmaceutical Class | Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA214429 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00024-4512-24 (00024451224)
| NDC Package Code | 0024-4512-24 |
|---|---|
| Billing NDC | 00024451224 |
| Package | 24 TABLET in 1 DOSE PACK (0024-4512-24) |
| Marketing Start Date | 2021-07-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |